payday loans
payday loans
Skip to content

Accueil FMC Bibliographie
Listing des derniers articles parus

Dans cette rubrique on vous propose une revue de la littérature à travers une sélection d'abstracts d'articles originaux.
On essaiera de vous tenir informé des dernières nouveautés de recherche en matière de Pneumologie. On ne vous fournit que le résumé de l'article et le lien correspondant, pour accéder à l'article en full text vous devez être inscrits à la revue correspondante.
Cliquez ici pour consulter la liste des revues de Pneumologie disponibles en libre accès.

Filtrer par titres     Affichage # 
# Titre de l'article
251 Acid-suppressive medications during pregnancy and risk of asthma and allergy in children: A systematic review and meta-analysis
252 Connective tissue diseases, multimorbidity and the ageing lung.
253 Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug – resistant tuberculosis (2006–2015)
254 3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors.
255 Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients
256 [Mechanisms of non-specific airway hyperresponsiveness: Methacholine-induced alterations in airway architecture].
257 Management of children with interstitial lung diseases: the difficult issue of acute exacerbations
258 Occupational hypersensitivity pneumonitis: An EAACI Position paper.
259 Smoke-free legislation has potential to reduce the harmful effects of tobacco smoke exposure
260 Management of interstitial lung disease associated with connective tissue disease.
261 The role and choice criteria of antihistamines in allergy management - expert opinion.
262 Endoscopic Lung Volume Reduction: An Expert Panel Recommendation.
263 IFN-λ: A New Inducer of Local Immunity against Cancer and Infections.
264 Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
265 DNA damage and repair capacity in lymphocyte of chronic obstructive pulmonary diseases patients during physical exercise with oxygen supplementation
266 Physiological Mechanisms of Airways Hyperresponsiveness in Obese Asthma.
267 National Institutes of Health (NIH) Stroke Scale
268 Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis.
269 Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine.
270 Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?
271 Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
272 Chemotherapy for Tuberculous Meningitis
273 New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group.
274 Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
275 Lung tumors, COPD and immune response: is epigenetics the bottom line?
276 Percutaneous Rotational Pulmonary Thrombectomy
277 Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis.
278 Environmental Microbial Exposure and Protection against Asthma
279 Local lung deposition of ultrafine particles in healthy adults: experimental results and theoretical predictions.
280 Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis
281 Lung cancer: a rare indication for, but frequent complication after lung transplantation.
282 Lung sarcoidosis: Clinical features and therapeutic issues.
283 Non-Invasive Assessment of Pulmonary Vascular Resistance in Pulmonary Hypertension: Current Knowledge and Future Direction.
284 Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
285 Periostin: The bone and beyond.
286 Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways.
287 Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
288 Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
289 FDG-PET parameters predicting mediastinal malignancy in lung cancer.
290 Lung-gut crosstalk: evidence, mechanisms and implications for the mucosal inflammatory diseases.
291 Genetic Modification of the Lung Directed Toward Treatment of Human Disease.
292 Allergen immunotherapy for insect venom allergy: protocol for a systematic review.
293 Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?
294 Molecular testing patterns in metastatic non-small cell lung cancer.
295 New Therapies for Asthma and COPD.
296 Indoor microbial communities: Influence on asthma severity in atopic and nonatopic children
297 How Do Dual Long-acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
298 International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics
299 Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges.
300 Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
 
<< Début < Précédent 1 2 3 4 5 6 7 8 9 10 Suivant > Fin >>
Page 6 sur 198

find-us-on-facebook-2

United4LungHealth

image001

World Allergy Week 2017 The Agony of Hives

WCOPDday2017



PubMed Logo
Word

 To: 

Langtolang Dictionary

CNP2017

50x50_firefoxsafari_iconGchrome

Notre site est optimisé pour les Navigateurs suivants : Firefox, Safari et Google Chrome. Cliquez sur l'un des logos ci-dessus pour le télécharger et l'installer gratuitement.

Tabac

Accueil FMC Bibliographie Top